Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
898 Ergebnisse
| MR3SQ5 |  | Regeneron Pharmaceuticals Inc./OS/Call [700]/MS | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | 750,000 | - | - | - | - | 17.06.2027 | 0,100 | Morgan Stanley | |
| SX5KQ9 | Regeneron Pharmaceuticals Inc./OS/Call [700]/SOC | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,937 % | 0,452 | -0,236 | 9,480 | 18.09.2026 | 0,100 | Société Générale | ||
| FA6MCX | Regeneron Pharmaceuticals Inc./OS/Call [700]/SOC | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,050 % | 0,515 | -0,155 | 5,841 | 18.12.2026 | 0,100 | Société Générale | ||
| FD48N7 | Regeneron Pharmaceuticals Inc./OS/Call [700]/SOC | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,372 % | 0,545 | -0,125 | 4,602 | 19.03.2027 | 0,100 | Société Générale | ||
| FD51ET | Regeneron Pharmaceuticals Inc./OS/Call [700]/SOC | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,744 % | 0,572 | -0,111 | 3,832 | 17.06.2027 | 0,100 | Société Générale | ||
| VY3N31 | | Regeneron Pharmaceuticals Inc./OS/Call [700]/VONT | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,682 % | 0,417 | -0,036 | 11,874 | 21.08.2026 | 0,010 | Vontobel | |
| VY3N75 | | Regeneron Pharmaceuticals Inc./OS/Call [700]/VONT | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,028 % | 0,514 | -0,015 | 5,849 | 18.12.2026 | 0,010 | Vontobel | |
| VY3NR0 | | Regeneron Pharmaceuticals Inc./OS/Call [700]/VONT | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,481 % | 0,525 | -0,014 | 5,445 | 15.01.2027 | 0,010 | Vontobel | |
| VY5LQ7 | | Regeneron Pharmaceuticals Inc./OS/Call [700]/VONT | - | - | 700,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,919 % | 0,450 | -0,024 | 9,502 | 18.09.2026 | 0,010 | Vontobel | |
| GW0VJ1 | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,023 % | 0,530 | -0,013 | 4,611 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0VJJ | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,096 % | 0,554 | -0,011 | 3,950 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW0VJN | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,302 % | 0,506 | -0,014 | 5,447 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW1J0W | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,651 % | 0,591 | -0,009 | 3,067 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1J0Y | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,569 % | 0,591 | -0,009 | 3,070 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K4C | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,948 % | 0,574 | -0,010 | 3,394 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K5G | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,125 % | 0,598 | -0,009 | 2,949 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K59 | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,096 % | 0,554 | -0,011 | 3,950 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3SC3 | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,769 % | 0,605 | -0,008 | 2,845 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QGN | Regeneron Pharmaceuticals Inc./OS/Call [710]/GOLDS | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,956 % | 0,618 | -0,008 | 2,668 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JF9RG6 | Regeneron Pharmaceuticals Inc./OS/Call [710]/JPM | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,349 % | 0,486 | -0,015 | 6,257 | 18.12.2026 | 0,010 | JP Morgan | ||
| JH48WD | Regeneron Pharmaceuticals Inc./OS/Call [710]/JPM | - | - | 710,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,094 % | 0,405 | -0,022 | 10,424 | 18.09.2026 | 0,010 | JP Morgan | ||
| GW02S3 | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,747 % | 0,561 | -0,010 | 3,454 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02SH | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,713 % | 0,511 | -0,013 | 4,728 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW02VZ | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,795 % | 0,539 | -0,011 | 4,030 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW062K | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,390 % | 0,585 | -0,009 | 2,970 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J0V | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,751 % | 0,580 | -0,009 | 3,093 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1J0X | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,399 % | 0,583 | -0,009 | 3,052 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K4G | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,747 % | 0,561 | -0,010 | 3,454 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K50 | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,824 % | 0,587 | -0,009 | 2,996 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K7L | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,913 % | 0,538 | -0,011 | 4,028 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3SBY | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,747 % | 0,596 | -0,008 | 2,871 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QFJ | Regeneron Pharmaceuticals Inc./OS/Call [720]/GOLDS | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,331 % | 0,609 | -0,008 | 2,672 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JF9RG7 | Regeneron Pharmaceuticals Inc./OS/Call [720]/JPM | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,486 % | 0,464 | -0,015 | 6,384 | 18.12.2026 | 0,010 | JP Morgan | ||
| JH48WE | Regeneron Pharmaceuticals Inc./OS/Call [720]/JPM | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,149 % | 0,367 | -0,021 | 10,846 | 18.09.2026 | 0,010 | JP Morgan | ||
| JE7P3C | Regeneron Pharmaceuticals Inc./OS/Call [720]/JPMD | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,112 % | 0,478 | -0,014 | 5,894 | 15.01.2027 | 0,010 | JP Morgan | ||
| JE8FTW | Regeneron Pharmaceuticals Inc./OS/Call [720]/JPMD | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,205 % | 0,513 | -0,013 | 4,671 | 19.03.2027 | 0,010 | JP Morgan | ||
| JY0CFS | Regeneron Pharmaceuticals Inc./OS/Call [720]/JPMD | - | - | 720,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,725 % | 0,313 | -0,029 | 14,238 | 21.08.2026 | 0,010 | JP Morgan | ||
| JF9RG8 | Regeneron Pharmaceuticals Inc./OS/Call [725]/JPM | - | - | 725,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,358 % | 0,450 | -0,015 | 6,494 | 18.12.2026 | 0,010 | JP Morgan | ||
| MJ6V33 | | Regeneron Pharmaceuticals Inc./OS/Call [725]/MS | - | - | 725,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,598 % | 0,463 | -0,016 | 5,953 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM14TL | | Regeneron Pharmaceuticals Inc./OS/Call [725]/MS | - | - | 725,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,715 % | 0,540 | -0,012 | 3,806 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5GYW | | Regeneron Pharmaceuticals Inc./OS/Call [725]/MS | - | - | 725,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,039 % | 0,377 | -0,024 | 9,547 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN1HGP | | Regeneron Pharmaceuticals Inc./OS/Call [725]/MS | - | - | 725,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,332 % | 0,588 | -0,010 | 2,851 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6F45 | | Regeneron Pharmaceuticals Inc./OS/Call [725]/MS | - | - | 725,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,191 % | 0,506 | -0,013 | 4,607 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR3CF2 | | Regeneron Pharmaceuticals Inc./OS/Call [725]/MS | - | - | 725,000 | call | Regeneron Pharmaceuticals Inc. | - | 51,715 % | 0,630 | -0,009 | 2,299 | 16.06.2028 | 0,010 | Morgan Stanley | |
| VY3N35 | | Regeneron Pharmaceuticals Inc./OS/Call [725]/VONT | - | - | 725,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,755 % | 0,312 | -0,032 | 13,298 | 21.08.2026 | 0,010 | Vontobel | |
| GW0VJ9 | Regeneron Pharmaceuticals Inc./OS/Call [730]/GOLDS | - | - | 730,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,193 % | 0,493 | -0,012 | 4,868 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0VHY | Regeneron Pharmaceuticals Inc./OS/Call [730]/GOLDS | - | - | 730,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,411 % | 0,523 | -0,011 | 4,129 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW0VJS | Regeneron Pharmaceuticals Inc./OS/Call [730]/GOLDS | - | - | 730,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,028 % | 0,464 | -0,014 | 5,719 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW1J0B | Regeneron Pharmaceuticals Inc./OS/Call [730]/GOLDS | - | - | 730,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,436 % | 0,569 | -0,009 | 3,145 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1J10 | Regeneron Pharmaceuticals Inc./OS/Call [730]/GOLDS | - | - | 730,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,432 % | 0,569 | -0,009 | 3,145 | 17.12.2027 | 0,010 | Goldman Sachs |